Sunday, July 26

● Latest

U.S. An FDA panel backs wider access to gray-market peptides, over its own scientists' doubts Los Angeles A Koreatown muralist paints back the Korean culture that vanished from its walls World Suspect in the deadly Berlin Pride ramming is shot dead as officials call it Islamist terror World Punch, the baby monkey who clung to a plushie, turns 1 with 2,500 birthday cards World A NASA astronaut and two cosmonauts land in Kazakhstan after 241 days in orbit Los Angeles A crash involving a Waymo in Pico-Union hospitalizes one, with the robot car's role still unclear Entertainment Eight years after Jonathan Gold's death, City of Gold's director on the LA he'd be writing now Los Angeles At 67, a Palos Verdes runner chases a 19th straight Badwater 135 finish as the clock tightens U.S. An FDA panel backs wider access to gray-market peptides, over its own scientists' doubts Los Angeles A Koreatown muralist paints back the Korean culture that vanished from its walls World Suspect in the deadly Berlin Pride ramming is shot dead as officials call it Islamist terror World Punch, the baby monkey who clung to a plushie, turns 1 with 2,500 birthday cards World A NASA astronaut and two cosmonauts land in Kazakhstan after 241 days in orbit Los Angeles A crash involving a Waymo in Pico-Union hospitalizes one, with the robot car's role still unclear Entertainment Eight years after Jonathan Gold's death, City of Gold's director on the LA he'd be writing now Los Angeles At 67, a Palos Verdes runner chases a 19th straight Badwater 135 finish as the clock tightens

Topic: compounding-pharmacies

A syringe and vial

Sunday, 7/26, 07:56 PM

An FDA panel backs wider access to gray-market peptides, over its own scientists' doubts

An FDA advisory panel voted by narrow margins to recommend letting specialized compounding pharmacies make six of seven peptides now sold on a booming online gray market, from BPC-157 to TB-500.
FDA scientists warned there are few or no human trials and real risks, and two panelists said they could not vote yes.
Any rule change could take until 2028.

compounding-pharmacies — news and stories on this topic

This page collects all of the Los Angeles Herald's coverage of compounding-pharmacies. Follow the topic from one place: new stories appear here automatically as more is published. That way you stay on top of how the situation develops.

Looking for the bigger picture? Browse Los Angeles news, U.S. news, world news and politics, or head back to the front page for the day's top stories.